| Nombre del producto |
(±)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole |
| Nombre en inglés |
(±)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole; (R)-4,5,6,7-Tetrahydro-Benzothiazole-2,6-Diamine; (+)-(6R)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole; (+)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole(intermidiate of Pramipexole); (6R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole; (6R)-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (R)-4,5,6,7-Tetrahydro-2,6-benzothiazolediamine; R-2,6-Diamino-4,5,6,7-tetrahydroben-zothiazole; (+)-2,6-Diamino-4,5,6,7-Tetrahydrobenzothiazole |
| Fórmula molecular |
C7H11N3S |
| Peso Molecular |
169.2473 |
| InChI |
InChI=1/C7H11N3S/c8-4-1-2-5-6(3-4)11-7(9)10-5/h4H,1-3,8H2,(H2,9,10)/t4-/m1/s1 |
| Número de registro CAS |
106092-11-9 |
| Estructura Molecular |
|
| Densidad |
1.313g/cm3 |
| Punto de ebullición |
359°C at 760 mmHg |
| Índice de refracción |
1.655 |
| Punto de inflamación |
170.9°C |
| Presión de vapor |
2.45E-05mmHg at 25°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
